EGFR and lung adenocarcinoma: Nevertheless, a series of data suggest that the mutational load of lung adenocarcinoma in non-smoker patients (where the chance of detecting the EGFR mutation is the highest) is significantly lower [43], and that few (but critical) mutations may be enough to switch cells from normal to malignant [44].